New publication on AAV Vector Characterization: Validating Quantitative TEM for Partially Filled Particles

We are proud to announce that Our latest research collaborated with Viralgen, "Orthogonal approaches to AAV vector characterization: Validating quantitative TEM for partially filled particles" has been published in Molecular Therapy - Methods & Clinical Development.

This work offers a significant step forward in ensuring the quality and consistency of AAV-based medicines, ultimately helping to bring safer and more effective treatments to patients. 

About QuTEM

QuTEM is a world-leading provider of GMP-certified TEM-services and quality control analyses of nanoparticles, based in Stockholm, Sweden. Our dedicated team of experts work in close partnership with our clients to provide analysis solutions and support.

With nearly two decades of industry experience, a profound proficiency in interdisciplinary sciences, and an unwavering commitment to excellence, we proudly stand as the premier choice in providing TEM services.

Using latest generation instruments together with Gridsee, our proprietary software developed in house tuned for image analysis, we developed validated methodologies to ensure the delivery of high-quality services and reliable data to our customers.